🇦🇪 Hu38Sb19 in United Arab Emirates

Hu38Sb19 (isatuximab) regulatory status in United Arab Emirates.

Marketing authorisation

MOH

  • Status: likely_approved

Hu38Sb19 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in United Arab Emirates

Frequently asked questions

Is Hu38Sb19 approved in United Arab Emirates?

Yes. MOH has authorised it.

Who is the marketing authorisation holder for Hu38Sb19 in United Arab Emirates?

Sanofi is the originator. The local marketing authorisation holder may differ — check the official source linked above.